Robert J. Spiegel

Insider Reports History

Entity
Individual
Location
C/O Geron Corporation, 230 Constitution Drive, Menlo Park, CA
Signature
/s/ Robert J. Spiegel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert J. Spiegel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GERON CORP Director Common Stock 170K $776K $4.56 Sep 30, 2024 Direct
Cyclacel Pharmaceuticals, Inc. Director Common Stock 39.4K $131K $3.32 Jun 30, 2023 Direct
RenovoRx, Inc. Director Common Stock 41K $42.8K $1.05 Jan 26, 2024 Direct
Athenex, Inc. Director Common Stock 4.59K $6.25K $1.36 Apr 21, 2023 Direct
GERON CORP Director Stock Option (right to buy) 180K May 9, 2024 Direct
Cyclacel Pharmaceuticals, Inc. Director Stock Option (right to buy) 42.4K Jun 30, 2023 Direct
RenovoRx, Inc. Director Warrants 41K Jan 26, 2024 Direct
RenovoRx, Inc. Director Stock Options (right to buy) 25.1K Oct 1, 2023 Direct
RenovoRx, Inc. Director Stock Options (right to buy) 25.1K Oct 1, 2024 Direct
Ayala Pharmaceuticals, Inc. Director Stock Option 1.17K Jan 19, 2023 Direct
Athenex, Inc. Director Stock Option (Right to Buy) 875 Apr 21, 2023 Direct
Old Ayala, Inc Director Stock Option (right to buy) 0 Jan 19, 2023 Direct

Insider Reports Filed by Robert J. Spiegel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNXT RenovoRx, Inc. Oct 1, 2024 1 $0 4 Oct 2, 2024 Director
GERN GERON CORP Sep 30, 2024 1 $0 4 Oct 1, 2024 Director
GERN GERON CORP May 9, 2024 1 $0 4 May 10, 2024 Director
GERN GERON CORP Mar 29, 2024 2 $0 4 Jun 28, 2024 Director
RNXT RenovoRx, Inc. Jan 26, 2024 2 $0 4 Jan 30, 2024 Director
GERN GERON CORP Dec 29, 2023 1 $0 4 Jan 3, 2024 Director
RNXT RenovoRx, Inc. Oct 1, 2023 1 $0 4 Oct 2, 2023 Director
GERN GERON CORP Sep 29, 2023 1 $0 4 Oct 2, 2023 Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 30, 2023 2 $0 4 Jul 3, 2023 Director
GERN GERON CORP Jun 30, 2023 1 $0 4 Jun 30, 2023 Director
GERN GERON CORP May 31, 2023 1 $0 4 Jun 2, 2023 Director
RNXT RenovoRx, Inc. Apr 25, 2023 1 $0 4 Apr 27, 2023 Director
RNXT RenovoRx, Inc. Apr 25, 2023 0 $0 3 Apr 27, 2023 Director
ATNXQ Athenex, Inc. Apr 21, 2023 1 $3K 4 Apr 24, 2023 Director
GERN GERON CORP Mar 31, 2023 1 $0 4 Apr 3, 2023 Director
AYLA Old Ayala, Inc Jan 19, 2023 4 $0 4 Jan 23, 2023 Director
ADXS Ayala Pharmaceuticals, Inc. Jan 19, 2023 4 $0 4 Jan 23, 2023 Director
ADXS Ayala Pharmaceuticals, Inc. Jan 19, 2023 0 $0 3 Jan 23, 2023 Director
ATNXQ Athenex, Inc. Jan 13, 2023 1 $3K 4 Jan 17, 2023 Director
GERN GERON CORP Dec 30, 2022 1 $0 4 Jan 3, 2023 Director
ATNXQ Athenex, Inc. Oct 7, 2022 1 $3K 4 Oct 12, 2022 Director
GERN GERON CORP Sep 30, 2022 1 $0 4 Oct 3, 2022 Director
ATNXQ Athenex, Inc. Aug 3, 2022 2 $0 4 Aug 30, 2022 Director
ATNXQ Athenex, Inc. Jul 20, 2022 1 $3K 4 Jul 21, 2022 Director
GERN GERON CORP Jun 30, 2022 1 $0 4 Jul 1, 2022 Director
ATNXQ Athenex, Inc. Jun 28, 2022 1 $0 4 Jun 29, 2022 Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
AYLA Ayala Pharmaceuticals, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
GERN GERON CORP May 10, 2022 1 $0 4 May 11, 2022 Director
ATNXQ Athenex, Inc. Apr 8, 2022 1 $3K 4 Apr 11, 2022 Director
GERN GERON CORP Mar 31, 2022 1 $0 4 Apr 1, 2022 Director
GERN GERON CORP Dec 31, 2021 1 $0 4 Jan 3, 2022 Director
GERN GERON CORP Sep 30, 2021 1 $0 4 Oct 1, 2021 Director
ATNXQ Athenex, Inc. Aug 3, 2021 2 $0 4 Aug 5, 2021 Director
GERN GERON CORP Jun 30, 2021 1 $0 4 Jul 1, 2021 Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 15, 2021 2 $0 4 Jun 17, 2021 Director
AYLA Ayala Pharmaceuticals, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
GERN GERON CORP May 11, 2021 1 $0 4 May 13, 2021 Director